Is Lineage Cell Therapeutics Inc (LCTX) Stock at the Top of the Biotechnology Industry?

A rating of 88 puts Lineage Cell Therapeutics Inc (LCTX) near the top of the Biotechnology industry according to InvestorsObserver. Lineage Cell Therapeutics Inc's score of 88 means it scores higher than 88% of stocks in the industry. Lineage Cell Therapeutics Inc also received an overall rating of 66, putting it above 66% of all stocks. Biotechnology is ranked 67 out of the 148 industries.

LCTX has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on LCTX!

See Full LCTX Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Lineage Cell Therapeutics Inc Stock Today?

Lineage Cell Therapeutics Inc (LCTX) stock is trading at $1.30 as of 10:59 AM on Friday, Sep 15, a decline of -$0.01, or -0.76% from the previous closing price of $1.31. The stock has traded between $1.29 and $1.34 so far today. Volume today is less active than usual. So far 168,371 shares have traded compared to average volume of 355,197 shares. Click Here to get the full Stock Report for Lineage Cell Therapeutics Inc stock.